| Beth DelGiacco |
|
ARGENX SE |
VP and Global Head of Corporate Communications & Investor Relations |
Biotechnology: Biological Products (No Diagnostic Substances) |
|
Netherlands |
| James Dentzer |
jde*****@curis.com
|
Curis |
President, CEO & Director |
Biotechnology |
|
United States |
| Mark Noel |
mno**@curis.com
|
Curis |
Vice President of Technology Management & Intellectual Property |
Biotechnology |
|
United States |
| Elif McDonald |
emc******@curis.com
|
Curis |
VP of Investor Relations & Corporate Communications |
Biotechnology |
|
United States |
| Reinhard Roemeling |
rro*******@curis.com
|
Curis |
Senior Vice President of Clinical Development |
Biotechnology |
|
United States |
| Jacob Thaysen |
jth*****@illumina.com
|
ILLUMINA, INC. |
CEO & Director |
Medical Specialities |
|
United States |
| Stephanie Campos |
sca****@illumina.com
|
ILLUMINA, INC. |
President |
Medical Specialities |
|
United States |
| Kevin Pegels |
kpe****@illumina.com
|
ILLUMINA, INC. |
Chief of Global Operations |
Medical Specialities |
|
United States |
| Scott Ericksen |
ser******@illumina.com
|
ILLUMINA, INC. |
VP & Chief Accounting Officer |
Medical Specialities |
|
United States |
| Steven Barnard |
sba*****@illumina.com
|
ILLUMINA, INC. |
Chief Technology Officer |
Medical Specialities |
|
United States |